BIOSYNEX
Identification

Listing sponsor / Agent
EUROLAND FINANCE
Symbol
XXXXX
ISIN code
FR0011005933
Exchange / Market
Euronext
Trading location
Paris
Products family
Stocks
Market organization
Alternext
ICB
Medical Supplies
Activity description
Biosynex mission is to supply professionals (clinical labs, physicians) with innovative rapid diagnostic kits that enable them to get rapid information in order to improve patients monitoring in both resource-limited settings and advanced medical services.
Biosynex is currently focusing its expertise in four areas where Point of Care testing (POC) will take a growing place in the coming years in an attempt to reduce healthcare costs and bring flexibility to healthcare professionals:
- Tropical diseases
- Emergency markers
- Infectious diseases
- Autoimmunity
Fifteen employees are currently working in the company including 5 scientists in R&D department.
Website address
http://biosynex.nexenservices.com
Issuer website
http://biosynex.nexenservices.com
Operation
IPO date
Mon 21/03/2011
IPO type
Public offer NYSE Alternext à Paris
IPO type
Initial Public offering
Catégorie
IPO